Skip to content
Research Article Open access CC BY 4.0

Prostate Cancer Incidence in Calabar - Nigeria

G. A. Ebughe, I. A. Ekanem, O. E. Omoronyia, M. A. Nnoli, E. E. Ikpi, T. I. Ugbem

Journal of Advances in Medicine and Medical Research · pp. 1–10 · Published 14 Mar 2016

10.9734/BJMMR/2016/23503

Abstract

Aim: The aim of this study is to determine the incidence of prostate cancer in men living in Calabar- Nigeria, which has not been determined up till now. Study Design: A trend analysis of prostate cancer cases in Calabar between 1st January 2004 to 31st December 2013. Place and Duration of Study: Calabar cancer registry, May to June 2015. Methodology: Record of prostate cancer cases in the Calabar cancer registry between 1st January  2004 and 31st December 2013,was accessed. The patients age, sex, place domiciled in the last one year; whether rural or urban as well as prostate cancer topography and morphology were obtained and analyzed. The population of males domiciled in Calabar was determined using the 2006 national population census data and 3.0% population growth as specified by the national population commission. Excluded are all male genital tract cancers outside prostate cancer .The data was subjected to statistical analysis using SPSS version 21. Results: Two hundred and seventy nine (279) prostate cancer cases were seen, with mean (SD) age of subjects being 64.2 (9.5) years, with a range 40 to 95 years. About 249 cases (89.3%) occurred in those who are 55 years or older at time of diagnosis, with the commonest age group being 60-64 years. The age specific incidence of prostate cancer is 89 per 100,000, both crude and adjusted incidence rates were highest in 2012 (69.4 and 97.4 per 100,000, respectively). There was significant decrease in incidence rates in the initial five years (2004-2008), and increase in rates in the following five years of study (2009-2013). Within the 5-year period from 2004 to 2008, there was an average annual decrease in incidence rate of 9.63% (95% CI: 6.1%-12.8%). However, within the 5-year period from 2009 to 2013, there was an average annual increase in incidence rate of 11.95% (95%CI: 8.72% to 13.04%). Conclusion: This epidemiologic study demonstrate the incidence of prostate cancer in Calabar, Nigeria, with a predominance of patients in the 60- 64 years age group. West African states have to scale up population screening and study of this neoplasm.

Calabar prostate cancer incidence males

References (67)

  1. 1 International Variation in Prostate Cancer Incidence and Mortality Rates [DOI]
  2. 2 Cancer incidence in Nigeria: A report from population-based cancer registries [DOI]
  3. 3 The worldwide epidemiology of prostate cancer: perspectives from autopsy studies.
  4. 4 Prostate cancer in young men: an important clinical entity [DOI]
  5. 5 Prostate cancer in Asian men [DOI]
  6. 6 Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa [DOI]
  7. 7 Nocturnal light pollution and underexposure to daytime sunlight: Complementary mechanisms of circadian disruption and related diseases [DOI]
  8. 8 Nationwide Cancer Incidence in Korea, 2003-2005 [DOI]
  9. 9 Empirical estimates of prostate cancer overdiagnosis by age and prostate-specific antigen [DOI]
  10. 10 Prevalence of theHOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes [DOI]
  11. 11 Trends of prostate cancer incidence and mortality in Shanghai, China from 1973 to 2009 [DOI]
  12. 12 A Diversity of Cancer Incidence and Mortality in West Asian Populations [DOI]
  13. 13 Mobile phones, mobile phone base stations and cancer: a review [DOI]
  14. 14 High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey.
  15. 15 Increased incidence of prostate cancer in Nigerians.
  16. 16 Cancer incidence in Abidjan, Ivory Coast [DOI]
  17. 17 Prevalence and characteristics of prostate cancer among participants of a community-based screening in Nigeria using serum prostate specific antigen and digital rectal examination [DOI]
  18. 18 Burden of Prostate Cancer in Southwestern Nigeria [DOI]
  19. 19 The role of hospital-based cancer registries in low and middle income countries—The Nigerian Case Study [DOI]
  20. 20 High Prevalence of Screen Detected Prostate Cancer in West Africans: Implications for Racial Disparity of Prostate Cancer [DOI]
  21. 21 Incidence of Cancers in Kuzestan Province of Iran: Trend from 2004 to 2008 [DOI]
  22. 22 Is prostate cancer screening cost‐effective? A microsimulation model of prostate‐specific antigen‐based screening for British Columbia, Canada [DOI]
  23. 23 The association between race and prostate cancer risk on initial biopsy in an equal access, multiethnic cohort [DOI]
  24. 24 Relative Value of Race, Family History and Prostate Specific Antigen as Indications for Early Initiation of Prostate Cancer Screening [DOI]
  25. 25 Trends in Cancer Incidence in Maputo, Mozambique, 1991–2008 [DOI]
  26. 26 An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? [DOI]
  27. 27 Screening for prostate cancer in the US? Reduce the harms and keep the benefit [DOI]
  28. 28 Prostate cancer incidence and mortality in the Spanish section of the European Randomized Study of Screening For Prostate Cancer (ERSPC) [DOI]
  29. 29 Prevalence of elevated serum prostate‐specific antigen in rural Nigeria [DOI]
  30. 30 Roots of prostate cancer in African-American men.
  31. 31 Mobile phone use and cancer [DOI]
  32. 32 Review of prostate cancer research in Nigeria [DOI]
  33. 33 Prostate Cancer Incidence in Turkey: An Epidemiological Study [DOI]
  34. 34 Prostate Cancer Susceptibility Loci Identified on Chromosome 12 in African Americans [DOI]
  35. 35 Prostate cancer awareness and screening among male public servants in Anambra State, Nigeria [DOI]
  36. 36 Transperineal versus transrectal prostate biopsy: Our findings in a tertiary health institution [DOI]
  37. 37 The feasibility of epidemiological research on prostate cancer in African men in Ibadan, Nigeria [DOI]
  38. 38 Cancer avancé de la prostate au Sénégal. Aspects diagnostiques à l’hôpital de Grand Yoff [DOI]
  39. 39 Prostate cancer risk is three-fold higher among men, aged 50-64, of African descent compared with men of Asian-Indian descent in Trinidad and Tobago.
  40. 40 Emergent trends in the reported incidence of prostate cancer in Nigeria [DOI]
  41. 41 Prostate cancer disease severity and country of origin among black men in the United States [DOI]
  42. 42 The Biology and Natural History of Prostate Cancer: A Short Introduction [DOI]
  43. 43 The association of plasma fatty acids with prostate cancer risk in Nigerians.
  44. 44 Overview of prostate cancer in indigenous black Africans and blacks of African ancestry in diaspora 1935-2007 [DOI]
  45. 45 Prostate cancer trends in Latvia during 1990–2012: Incidence, prevalence, mortality, and survival rates [DOI]
  46. 46 Ethnicity and its significance in the pathobiology of prostatic carcinoma in Southern Israel [DOI]
  47. 47 Mobile phones do not pose health risk, German survey shows [DOI]
  48. 48 Symptomatic spinal cord involvement in prostate cancer [DOI]
  49. 49 Prostate Cancer Epidemiology [DOI]
  50. 50 ecancermedicalscience [DOI]
  51. 51 Racial and Ethnic Disparities in Cancer Survival by Neighborhood Socioeconomic Status in Surveillance, Epidemiology, and End Results (SEER) Registries [DOI]
  52. 52 Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data [DOI]
  53. 53 Mobile Phone Use and Risk of Tumors: A Meta-Analysis [DOI]
  54. 54 Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci [DOI]
  55. 55 THE EPIDEMIOLOGY OF PROSTATE CANCER IN JAMAICA [DOI]
  56. 56 Individualized Estimates of Overdiagnosis in Screen-Detected Prostate Cancer [DOI]
  57. 57 Temporal trends and racial disparities in global prostate cancer prevalence.
  58. 58 Racial disparities in prostate cancer incidence rates by census division in the United States, 1999–2008 [DOI]
  59. 59 Impact of health system challenges on prostate cancer control: health care experiences in Nigeria [DOI]
  60. 60 Understanding Regional Variation in Medicare Expenditures for Initial Episodes of Prostate Cancer Care [DOI]
  61. 61 Knowledge and perceptions of prostate cancer among Nigerian male immigrants.
  62. 62 Cutaneous metastasis from prostate cancer in a nigerian: a case report and literature review.
  63. 63 Characterization of prostatic carcinoma among blacks: a continuation report.
  64. 64 Advanced carcinoma of the prostate presenting as a supraclavicular mass: Case report [DOI]
  65. 65 Gastric cancer. Some aspects of epidemiology, risk factors, treatment and survival.
  66. 66 Geographical epidemiology of prostate cancer: is there an association with infection?
  67. 67 [Screening for prostate cancer: present status and future perspectives].

Cited by 6

The Trends, Clinicopathological Features, and Treatment Outcomes of Patients with Prostate Cancer in Lokoja, Nigeria

Ayodeji Olusola Ogunmola, Adedayo S.A. Oyedeji, Oluseyi O. Fadahunsi · Journal of West African College of Surgeons · 2024

Analysis of annexin 7 gene of malignant prostatic hyperplasia-induced male wistar rats in the presence ofAnnona muricata

Joseph Bamidele Minari, Claribel Chidinma Chikezie · Journal of Taibah University for Science · 2019

Epidemiology of prostate cancer in Nigeria: a mixed methods systematic review

Chinonyerem O. Iheanacho, Okechukwu H. Enechukwu · Cancer Causes & Control · 2024

Showing 3 of 6 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

26

Page views

0

PDF downloads

3

Outbound clicks

6

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.